Cadrenal Therapeutics, Inc. Quarterly Liabilities, Current in USD from Q4 2022 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Cadrenal Therapeutics, Inc. quarterly Liabilities, Current history and growth rate from Q4 2022 to Q3 2024.
Cadrenal Therapeutics, Inc. Liabilities, Current for the quarter ending September 30, 2024 was $1.27M, a 125% increase year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$1.27M	+$703K	+125%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$1.46M	+$1.09M	+291%	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	$856K	+$455K	+113%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$827K	-$508K	-38%	Dec 31, 2023	10-Q	2024-11-07
Q3 2023	$564K			Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$374K			Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$402K			Mar 31, 2023	10-Q	2023-05-10
Q4 2022	$1.33M			Dec 31, 2022	10-K	2024-03-11

* An asterisk sign (*) next to the value indicates that the value is likely invalid.